nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—HTR2C—type 2 diabetes mellitus	0.257	0.667	CbGaD
Reboxetine—CYP3A4—type 2 diabetes mellitus	0.128	0.333	CbGaD
Reboxetine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.051	0.127	CbGbCtD
Reboxetine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0367	0.0909	CbGbCtD
Reboxetine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0327	0.081	CbGbCtD
Reboxetine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0236	0.0586	CbGbCtD
Reboxetine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0223	0.0552	CbGbCtD
Reboxetine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.022	0.0545	CbGbCtD
Reboxetine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0205	0.0509	CbGbCtD
Reboxetine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0196	0.0486	CbGbCtD
Reboxetine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0179	0.0444	CbGbCtD
Reboxetine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0169	0.0418	CbGbCtD
Reboxetine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0162	0.0403	CbGbCtD
Reboxetine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0162	0.0401	CbGbCtD
Reboxetine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0157	0.0388	CbGbCtD
Reboxetine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0142	0.0351	CbGbCtD
Reboxetine—ABCB1—Glyburide—type 2 diabetes mellitus	0.0121	0.03	CbGbCtD
Reboxetine—ABCB1—Losartan—type 2 diabetes mellitus	0.0111	0.0274	CbGbCtD
Reboxetine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0107	0.0266	CbGbCtD
Reboxetine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0103	0.0255	CbGbCtD
Reboxetine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0103	0.0255	CbGbCtD
Reboxetine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00973	0.0241	CbGbCtD
Reboxetine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00725	0.018	CbGbCtD
Reboxetine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00663	0.0164	CbGbCtD
Reboxetine—Atomoxetine—HTR2C—type 2 diabetes mellitus	0.000199	0.218	CrCbGaD
Reboxetine—Phenprocoumon—CYP3A4—type 2 diabetes mellitus	0.000159	0.174	CrCbGaD
Reboxetine—Phenprocoumon—ALB—type 2 diabetes mellitus	0.000139	0.152	CrCbGaD
Reboxetine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	0.000121	0.133	CrCbGaD
Reboxetine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	0.000121	0.132	CrCbGaD
Reboxetine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000109	0.000654	CcSEcCtD
Reboxetine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000108	0.000653	CcSEcCtD
Reboxetine—Chest pain—Metformin—type 2 diabetes mellitus	0.000108	0.000652	CcSEcCtD
Reboxetine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000108	0.000652	CcSEcCtD
Reboxetine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000108	0.000649	CcSEcCtD
Reboxetine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000108	0.000649	CcSEcCtD
Reboxetine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000108	0.000648	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000107	0.000648	CcSEcCtD
Reboxetine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000107	0.000647	CcSEcCtD
Reboxetine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000107	0.000646	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000107	0.000645	CcSEcCtD
Reboxetine—Discomfort—Metformin—type 2 diabetes mellitus	0.000107	0.000644	CcSEcCtD
Reboxetine—Nausea—Glipizide—type 2 diabetes mellitus	0.000107	0.000642	CcSEcCtD
Reboxetine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000106	0.000641	CcSEcCtD
Reboxetine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000106	0.000641	CcSEcCtD
Reboxetine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000106	0.000639	CcSEcCtD
Reboxetine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000106	0.000639	CcSEcCtD
Reboxetine—Tremor—Losartan—type 2 diabetes mellitus	0.000106	0.000637	CcSEcCtD
Reboxetine—Rash—Glimepiride—type 2 diabetes mellitus	0.000106	0.000636	CcSEcCtD
Reboxetine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000105	0.000636	CcSEcCtD
Reboxetine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000105	0.000635	CcSEcCtD
Reboxetine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000105	0.000634	CcSEcCtD
Reboxetine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000105	0.000634	CcSEcCtD
Reboxetine—Headache—Glimepiride—type 2 diabetes mellitus	0.000105	0.000632	CcSEcCtD
Reboxetine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000105	0.000631	CcSEcCtD
Reboxetine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000105	0.00063	CcSEcCtD
Reboxetine—Anaemia—Losartan—type 2 diabetes mellitus	0.000104	0.000629	CcSEcCtD
Reboxetine—Agitation—Losartan—type 2 diabetes mellitus	0.000104	0.000625	CcSEcCtD
Reboxetine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000104	0.000625	CcSEcCtD
Reboxetine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000104	0.000624	CcSEcCtD
Reboxetine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000623	CcSEcCtD
Reboxetine—Infection—Metformin—type 2 diabetes mellitus	0.000103	0.000621	CcSEcCtD
Reboxetine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000103	0.000621	CcSEcCtD
Reboxetine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000102	0.000616	CcSEcCtD
Reboxetine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000102	0.000616	CcSEcCtD
Reboxetine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000102	0.000615	CcSEcCtD
Reboxetine—Shock—Metformin—type 2 diabetes mellitus	0.000102	0.000615	CcSEcCtD
Reboxetine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000102	0.000613	CcSEcCtD
Reboxetine—Malaise—Losartan—type 2 diabetes mellitus	0.000102	0.000613	CcSEcCtD
Reboxetine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000102	0.000613	CcSEcCtD
Reboxetine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000102	0.000613	CcSEcCtD
Reboxetine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000102	0.000613	CcSEcCtD
Reboxetine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000102	0.000612	CcSEcCtD
Reboxetine—Vertigo—Losartan—type 2 diabetes mellitus	0.000101	0.000611	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000101	0.000611	CcSEcCtD
Reboxetine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000101	0.000611	CcSEcCtD
Reboxetine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000101	0.00061	CcSEcCtD
Reboxetine—Syncope—Losartan—type 2 diabetes mellitus	0.000101	0.00061	CcSEcCtD
Reboxetine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000101	0.000609	CcSEcCtD
Reboxetine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000101	0.000609	CcSEcCtD
Reboxetine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000101	0.000608	CcSEcCtD
Reboxetine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000101	0.000607	CcSEcCtD
Reboxetine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.0001	0.000605	CcSEcCtD
Reboxetine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.0001	0.000604	CcSEcCtD
Reboxetine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.0001	0.000604	CcSEcCtD
Reboxetine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.0001	0.000604	CcSEcCtD
Reboxetine—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.98e-05	0.000602	CcSEcCtD
Reboxetine—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.98e-05	0.000602	CcSEcCtD
Reboxetine—Palpitations—Losartan—type 2 diabetes mellitus	9.97e-05	0.000601	CcSEcCtD
Reboxetine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	9.94e-05	0.109	CrCbGaD
Reboxetine—Nausea—Glimepiride—type 2 diabetes mellitus	9.94e-05	0.000599	CcSEcCtD
Reboxetine—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.92e-05	0.000598	CcSEcCtD
Reboxetine—Nausea—Sitagliptin—type 2 diabetes mellitus	9.91e-05	0.000597	CcSEcCtD
Reboxetine—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.9e-05	0.000597	CcSEcCtD
Reboxetine—Asthenia—Glyburide—type 2 diabetes mellitus	9.9e-05	0.000597	CcSEcCtD
Reboxetine—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.9e-05	0.000597	CcSEcCtD
Reboxetine—Anorexia—Metformin—type 2 diabetes mellitus	9.88e-05	0.000596	CcSEcCtD
Reboxetine—Urticaria—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.000594	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.83e-05	0.000593	CcSEcCtD
Reboxetine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.8e-05	0.000591	CcSEcCtD
Reboxetine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.8e-05	0.000591	CcSEcCtD
Reboxetine—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.78e-05	0.00059	CcSEcCtD
Reboxetine—Mental disorder—Ramipril—type 2 diabetes mellitus	9.74e-05	0.000587	CcSEcCtD
Reboxetine—Constipation—Valsartan—type 2 diabetes mellitus	9.74e-05	0.000587	CcSEcCtD
Reboxetine—Infection—Irbesartan—type 2 diabetes mellitus	9.72e-05	0.000586	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.71e-05	0.000586	CcSEcCtD
Reboxetine—Hypotension—Metformin—type 2 diabetes mellitus	9.69e-05	0.000584	CcSEcCtD
Reboxetine—Malnutrition—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000583	CcSEcCtD
Reboxetine—Shock—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.00058	CcSEcCtD
Reboxetine—Chest pain—Losartan—type 2 diabetes mellitus	9.61e-05	0.000579	CcSEcCtD
Reboxetine—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.6e-05	0.000579	CcSEcCtD
Reboxetine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000578	CcSEcCtD
Reboxetine—Anxiety—Losartan—type 2 diabetes mellitus	9.57e-05	0.000577	CcSEcCtD
Reboxetine—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.55e-05	0.000576	CcSEcCtD
Reboxetine—Rash—Bromocriptine—type 2 diabetes mellitus	9.52e-05	0.000574	CcSEcCtD
Reboxetine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.51e-05	0.000573	CcSEcCtD
Reboxetine—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.5e-05	0.000573	CcSEcCtD
Reboxetine—Tension—Ramipril—type 2 diabetes mellitus	9.49e-05	0.000572	CcSEcCtD
Reboxetine—Discomfort—Losartan—type 2 diabetes mellitus	9.49e-05	0.000572	CcSEcCtD
Reboxetine—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000571	CcSEcCtD
Reboxetine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.46e-05	0.00057	CcSEcCtD
Reboxetine—Headache—Bromocriptine—type 2 diabetes mellitus	9.46e-05	0.00057	CcSEcCtD
Reboxetine—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.44e-05	0.000569	CcSEcCtD
Reboxetine—Nervousness—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000566	CcSEcCtD
Reboxetine—Dry mouth—Losartan—type 2 diabetes mellitus	9.39e-05	0.000566	CcSEcCtD
Reboxetine—Anorexia—Irbesartan—type 2 diabetes mellitus	9.33e-05	0.000562	CcSEcCtD
Reboxetine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.31e-05	0.000561	CcSEcCtD
Reboxetine—Paraesthesia—Metformin—type 2 diabetes mellitus	9.31e-05	0.000561	CcSEcCtD
Reboxetine—Confusional state—Losartan—type 2 diabetes mellitus	9.28e-05	0.00056	CcSEcCtD
Reboxetine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.27e-05	0.000559	CcSEcCtD
Reboxetine—Dyspnoea—Metformin—type 2 diabetes mellitus	9.24e-05	0.000557	CcSEcCtD
Reboxetine—Somnolence—Metformin—type 2 diabetes mellitus	9.22e-05	0.000556	CcSEcCtD
Reboxetine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.2e-05	0.000555	CcSEcCtD
Reboxetine—Infection—Losartan—type 2 diabetes mellitus	9.15e-05	0.000552	CcSEcCtD
Reboxetine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000551	CcSEcCtD
Reboxetine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.13e-05	0.00055	CcSEcCtD
Reboxetine—Dyspepsia—Metformin—type 2 diabetes mellitus	9.13e-05	0.00055	CcSEcCtD
Reboxetine—Tremor—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000546	CcSEcCtD
Reboxetine—Shock—Losartan—type 2 diabetes mellitus	9.06e-05	0.000546	CcSEcCtD
Reboxetine—Urticaria—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000545	CcSEcCtD
Reboxetine—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.03e-05	0.000544	CcSEcCtD
Reboxetine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.01e-05	0.000543	CcSEcCtD
Reboxetine—Abdominal pain—Valsartan—type 2 diabetes mellitus	9e-05	0.000543	CcSEcCtD
Reboxetine—Tachycardia—Losartan—type 2 diabetes mellitus	8.99e-05	0.000542	CcSEcCtD
Reboxetine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.98e-05	0.000541	CcSEcCtD
Reboxetine—Nausea—Bromocriptine—type 2 diabetes mellitus	8.97e-05	0.000541	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.95e-05	0.00054	CcSEcCtD
Reboxetine—Urticaria—Orlistat—type 2 diabetes mellitus	8.94e-05	0.000539	CcSEcCtD
Reboxetine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.9e-05	0.000537	CcSEcCtD
Reboxetine—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.89e-05	0.000536	CcSEcCtD
Reboxetine—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.89e-05	0.000536	CcSEcCtD
Reboxetine—Asthenia—Gliclazide—type 2 diabetes mellitus	8.89e-05	0.000536	CcSEcCtD
Reboxetine—Agitation—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000536	CcSEcCtD
Reboxetine—Constipation—Metformin—type 2 diabetes mellitus	8.87e-05	0.000535	CcSEcCtD
Reboxetine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.79e-05	0.00053	CcSEcCtD
Reboxetine—Anorexia—Losartan—type 2 diabetes mellitus	8.78e-05	0.000529	CcSEcCtD
Reboxetine—Vomiting—Glyburide—type 2 diabetes mellitus	8.77e-05	0.000529	CcSEcCtD
Reboxetine—Malaise—Ramipril—type 2 diabetes mellitus	8.72e-05	0.000526	CcSEcCtD
Reboxetine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.72e-05	0.000526	CcSEcCtD
Reboxetine—Rash—Glyburide—type 2 diabetes mellitus	8.7e-05	0.000525	CcSEcCtD
Reboxetine—Somnolence—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000524	CcSEcCtD
Reboxetine—Dermatitis—Glyburide—type 2 diabetes mellitus	8.69e-05	0.000524	CcSEcCtD
Reboxetine—Vertigo—Ramipril—type 2 diabetes mellitus	8.69e-05	0.000524	CcSEcCtD
Reboxetine—Syncope—Ramipril—type 2 diabetes mellitus	8.68e-05	0.000523	CcSEcCtD
Reboxetine—Leukopenia—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000522	CcSEcCtD
Reboxetine—Headache—Glyburide—type 2 diabetes mellitus	8.65e-05	0.000521	CcSEcCtD
Reboxetine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.61e-05	0.000519	CcSEcCtD
Reboxetine—Hypotension—Losartan—type 2 diabetes mellitus	8.6e-05	0.000519	CcSEcCtD
Reboxetine—Palpitations—Ramipril—type 2 diabetes mellitus	8.55e-05	0.000515	CcSEcCtD
Reboxetine—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.54e-05	0.000515	CcSEcCtD
Reboxetine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000513	CcSEcCtD
Reboxetine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.5e-05	0.000513	CcSEcCtD
Reboxetine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.48e-05	0.000511	CcSEcCtD
Reboxetine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.48e-05	0.000511	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.45e-05	0.000509	CcSEcCtD
Reboxetine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.39e-05	0.000506	CcSEcCtD
Reboxetine—Constipation—Irbesartan—type 2 diabetes mellitus	8.37e-05	0.000504	CcSEcCtD
Reboxetine—Insomnia—Losartan—type 2 diabetes mellitus	8.33e-05	0.000502	CcSEcCtD
Reboxetine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.29e-05	0.0005	CcSEcCtD
Reboxetine—Paraesthesia—Losartan—type 2 diabetes mellitus	8.27e-05	0.000498	CcSEcCtD
Reboxetine—Urticaria—Metformin—type 2 diabetes mellitus	8.24e-05	0.000497	CcSEcCtD
Reboxetine—Chest pain—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000497	CcSEcCtD
Reboxetine—Dyspnoea—Losartan—type 2 diabetes mellitus	8.21e-05	0.000495	CcSEcCtD
Reboxetine—Anxiety—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000495	CcSEcCtD
Reboxetine—Nausea—Glyburide—type 2 diabetes mellitus	8.2e-05	0.000494	CcSEcCtD
Reboxetine—Abdominal pain—Metformin—type 2 diabetes mellitus	8.2e-05	0.000494	CcSEcCtD
Reboxetine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.19e-05	0.000494	CcSEcCtD
Reboxetine—Somnolence—Losartan—type 2 diabetes mellitus	8.19e-05	0.000494	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000493	CcSEcCtD
Reboxetine—Asthenia—Valsartan—type 2 diabetes mellitus	8.17e-05	0.000492	CcSEcCtD
Reboxetine—Discomfort—Ramipril—type 2 diabetes mellitus	8.14e-05	0.000491	CcSEcCtD
Reboxetine—Dyspepsia—Losartan—type 2 diabetes mellitus	8.11e-05	0.000489	CcSEcCtD
Reboxetine—Asthenia—Orlistat—type 2 diabetes mellitus	8.07e-05	0.000487	CcSEcCtD
Reboxetine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.06e-05	0.000486	CcSEcCtD
Reboxetine—Dry mouth—Ramipril—type 2 diabetes mellitus	8.06e-05	0.000486	CcSEcCtD
Reboxetine—Decreased appetite—Losartan—type 2 diabetes mellitus	8e-05	0.000483	CcSEcCtD
Reboxetine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8e-05	0.000482	CcSEcCtD
Reboxetine—Confusional state—Ramipril—type 2 diabetes mellitus	7.96e-05	0.00048	CcSEcCtD
Reboxetine—Vomiting—Gliclazide—type 2 diabetes mellitus	7.88e-05	0.000475	CcSEcCtD
Reboxetine—Constipation—Losartan—type 2 diabetes mellitus	7.87e-05	0.000475	CcSEcCtD
Reboxetine—Rash—Gliclazide—type 2 diabetes mellitus	7.81e-05	0.000471	CcSEcCtD
Reboxetine—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.81e-05	0.000471	CcSEcCtD
Reboxetine—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.79e-05	0.00047	CcSEcCtD
Reboxetine—Urticaria—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000469	CcSEcCtD
Reboxetine—Shock—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000468	CcSEcCtD
Reboxetine—Headache—Gliclazide—type 2 diabetes mellitus	7.76e-05	0.000468	CcSEcCtD
Reboxetine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000467	CcSEcCtD
Reboxetine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.000466	CcSEcCtD
Reboxetine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.000466	CcSEcCtD
Reboxetine—Tachycardia—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000465	CcSEcCtD
Reboxetine—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.7e-05	0.000464	CcSEcCtD
Reboxetine—Skin disorder—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000462	CcSEcCtD
Reboxetine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.63e-05	0.00046	CcSEcCtD
Reboxetine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	7.59e-05	0.0831	CrCbGaD
Reboxetine—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.59e-05	0.000457	CcSEcCtD
Reboxetine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.53e-05	0.000454	CcSEcCtD
Reboxetine—Dizziness—Valsartan—type 2 diabetes mellitus	7.53e-05	0.000454	CcSEcCtD
Reboxetine—Anorexia—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000454	CcSEcCtD
Reboxetine—Dizziness—Orlistat—type 2 diabetes mellitus	7.44e-05	0.000449	CcSEcCtD
Reboxetine—Asthenia—Metformin—type 2 diabetes mellitus	7.44e-05	0.000448	CcSEcCtD
Reboxetine—Hypotension—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000445	CcSEcCtD
Reboxetine—Nausea—Gliclazide—type 2 diabetes mellitus	7.36e-05	0.000444	CcSEcCtD
Reboxetine—Urticaria—Losartan—type 2 diabetes mellitus	7.32e-05	0.000441	CcSEcCtD
Reboxetine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.28e-05	0.000439	CcSEcCtD
Reboxetine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.28e-05	0.000439	CcSEcCtD
Reboxetine—Vomiting—Valsartan—type 2 diabetes mellitus	7.24e-05	0.000436	CcSEcCtD
Reboxetine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000435	CcSEcCtD
Reboxetine—Rash—Valsartan—type 2 diabetes mellitus	7.18e-05	0.000433	CcSEcCtD
Reboxetine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.17e-05	0.000432	CcSEcCtD
Reboxetine—Vomiting—Orlistat—type 2 diabetes mellitus	7.15e-05	0.000431	CcSEcCtD
Reboxetine—Insomnia—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000431	CcSEcCtD
Reboxetine—Headache—Valsartan—type 2 diabetes mellitus	7.13e-05	0.00043	CcSEcCtD
Reboxetine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.09e-05	0.000428	CcSEcCtD
Reboxetine—Rash—Orlistat—type 2 diabetes mellitus	7.09e-05	0.000428	CcSEcCtD
Reboxetine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000427	CcSEcCtD
Reboxetine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.09e-05	0.000427	CcSEcCtD
Reboxetine—Headache—Orlistat—type 2 diabetes mellitus	7.05e-05	0.000425	CcSEcCtD
Reboxetine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.04e-05	0.000424	CcSEcCtD
Reboxetine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.000423	CcSEcCtD
Reboxetine—Somnolence—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000423	CcSEcCtD
Reboxetine—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.95e-05	0.000419	CcSEcCtD
Reboxetine—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000414	CcSEcCtD
Reboxetine—Dizziness—Metformin—type 2 diabetes mellitus	6.86e-05	0.000413	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000411	CcSEcCtD
Reboxetine—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.78e-05	0.000409	CcSEcCtD
Reboxetine—Nausea—Valsartan—type 2 diabetes mellitus	6.76e-05	0.000408	CcSEcCtD
Reboxetine—Constipation—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000407	CcSEcCtD
Reboxetine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000404	CcSEcCtD
Reboxetine—Nausea—Orlistat—type 2 diabetes mellitus	6.68e-05	0.000403	CcSEcCtD
Reboxetine—Asthenia—Losartan—type 2 diabetes mellitus	6.61e-05	0.000398	CcSEcCtD
Reboxetine—Vomiting—Metformin—type 2 diabetes mellitus	6.59e-05	0.000397	CcSEcCtD
Reboxetine—Rash—Metformin—type 2 diabetes mellitus	6.54e-05	0.000394	CcSEcCtD
Reboxetine—Dermatitis—Metformin—type 2 diabetes mellitus	6.53e-05	0.000394	CcSEcCtD
Reboxetine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000392	CcSEcCtD
Reboxetine—Headache—Metformin—type 2 diabetes mellitus	6.5e-05	0.000392	CcSEcCtD
Reboxetine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.00039	CcSEcCtD
Reboxetine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.46e-05	0.000389	CcSEcCtD
Reboxetine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.3e-05	0.00038	CcSEcCtD
Reboxetine—Urticaria—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000378	CcSEcCtD
Reboxetine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000376	CcSEcCtD
Reboxetine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000376	CcSEcCtD
Reboxetine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000375	CcSEcCtD
Reboxetine—Rash—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000372	CcSEcCtD
Reboxetine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.16e-05	0.000372	CcSEcCtD
Reboxetine—Nausea—Metformin—type 2 diabetes mellitus	6.16e-05	0.000371	CcSEcCtD
Reboxetine—Headache—Irbesartan—type 2 diabetes mellitus	6.13e-05	0.00037	CcSEcCtD
Reboxetine—Dizziness—Losartan—type 2 diabetes mellitus	6.09e-05	0.000367	CcSEcCtD
Reboxetine—Vomiting—Losartan—type 2 diabetes mellitus	5.85e-05	0.000353	CcSEcCtD
Reboxetine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000351	CcSEcCtD
Reboxetine—Nausea—Irbesartan—type 2 diabetes mellitus	5.81e-05	0.00035	CcSEcCtD
Reboxetine—Rash—Losartan—type 2 diabetes mellitus	5.81e-05	0.00035	CcSEcCtD
Reboxetine—Dermatitis—Losartan—type 2 diabetes mellitus	5.8e-05	0.00035	CcSEcCtD
Reboxetine—Headache—Losartan—type 2 diabetes mellitus	5.77e-05	0.000348	CcSEcCtD
Reboxetine—Asthenia—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000342	CcSEcCtD
Reboxetine—Nausea—Losartan—type 2 diabetes mellitus	5.47e-05	0.00033	CcSEcCtD
Reboxetine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000326	CcSEcCtD
Reboxetine—Dizziness—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000315	CcSEcCtD
Reboxetine—Vomiting—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000303	CcSEcCtD
Reboxetine—Rash—Ramipril—type 2 diabetes mellitus	4.98e-05	0.0003	CcSEcCtD
Reboxetine—Dermatitis—Ramipril—type 2 diabetes mellitus	4.97e-05	0.0003	CcSEcCtD
Reboxetine—Headache—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000298	CcSEcCtD
Reboxetine—Nausea—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000283	CcSEcCtD
Reboxetine—HTR2C—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.04e-05	0.000233	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.03e-05	0.000232	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.03e-05	0.000232	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.02e-05	0.000228	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.01e-05	0.000228	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.01e-05	0.000227	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.01e-05	0.000227	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.01e-05	0.000227	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.96e-06	0.000224	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.89e-06	0.000222	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	9.86e-06	0.000222	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	9.76e-06	0.000219	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	9.76e-06	0.000219	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	9.76e-06	0.000219	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	9.76e-06	0.000219	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.69e-06	0.000218	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	9.66e-06	0.000217	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	9.66e-06	0.000217	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	9.52e-06	0.000214	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.38e-06	0.000211	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	9.35e-06	0.00021	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.34e-06	0.00021	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	9.33e-06	0.00021	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	9.33e-06	0.00021	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	9.33e-06	0.00021	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	9.33e-06	0.00021	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.33e-06	0.00021	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.23e-06	0.000207	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GCG—type 2 diabetes mellitus	9.23e-06	0.000207	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	9.19e-06	0.000207	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	9.19e-06	0.000207	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	9.19e-06	0.000207	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	9.19e-06	0.000207	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.08e-06	0.000204	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.05e-06	0.000203	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	9.03e-06	0.000203	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.92e-06	0.0002	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	8.81e-06	0.000198	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	8.7e-06	0.000195	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.63e-06	0.000194	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.53e-06	0.000192	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.53e-06	0.000192	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.48e-06	0.000191	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.47e-06	0.00019	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.37e-06	0.000188	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	8.31e-06	0.000187	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	8.19e-06	0.000184	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	8.12e-06	0.000182	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.03e-06	0.00018	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	7.95e-06	0.000179	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	7.95e-06	0.000179	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.95e-06	0.000179	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.93e-06	0.000178	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.93e-06	0.000178	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.93e-06	0.000178	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.84e-06	0.000176	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AVP—type 2 diabetes mellitus	7.84e-06	0.000176	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.81e-06	0.000176	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	7.8e-06	0.000175	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.78e-06	0.000175	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	7.75e-06	0.000174	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	7.75e-06	0.000174	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	7.75e-06	0.000174	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	7.7e-06	0.000173	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.7e-06	0.000173	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	7.65e-06	0.000172	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.6e-06	0.000171	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.6e-06	0.000171	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOB—type 2 diabetes mellitus	7.58e-06	0.00017	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.56e-06	0.00017	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.55e-06	0.00017	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	7.49e-06	0.000168	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	7.49e-06	0.000168	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	7.48e-06	0.000168	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.46e-06	0.000168	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	7.35e-06	0.000165	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	7.34e-06	0.000165	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.32e-06	0.000164	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.32e-06	0.000164	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	7.3e-06	0.000164	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	7.3e-06	0.000164	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	7.3e-06	0.000164	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	7.26e-06	0.000163	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LPL—type 2 diabetes mellitus	7.24e-06	0.000163	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.19e-06	0.000162	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	7.13e-06	0.00016	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.09e-06	0.000159	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.07e-06	0.000159	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.07e-06	0.000159	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.07e-06	0.000159	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	7.05e-06	0.000158	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	6.95e-06	0.000156	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	6.95e-06	0.000156	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	6.95e-06	0.000156	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	6.82e-06	0.000153	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.79e-06	0.000153	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	6.76e-06	0.000152	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.67e-06	0.00015	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.65e-06	0.000149	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.63e-06	0.000149	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.62e-06	0.000149	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.55e-06	0.000147	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.55e-06	0.000147	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	6.55e-06	0.000147	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—C3—type 2 diabetes mellitus	6.52e-06	0.000146	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	6.43e-06	0.000145	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	6.37e-06	0.000143	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.36e-06	0.000143	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.29e-06	0.000141	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.29e-06	0.000141	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	6.24e-06	0.00014	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.22e-06	0.00014	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.22e-06	0.00014	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.2e-06	0.000139	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AGT—type 2 diabetes mellitus	6.19e-06	0.000139	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.13e-06	0.000138	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.09e-06	0.000137	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LEP—type 2 diabetes mellitus	6.07e-06	0.000136	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOE—type 2 diabetes mellitus	6.07e-06	0.000136	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.03e-06	0.000135	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	6.03e-06	0.000135	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.01e-06	0.000135	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.01e-06	0.000135	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.01e-06	0.000135	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.01e-06	0.000135	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	6e-06	0.000135	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.99e-06	0.000135	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.92e-06	0.000133	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.92e-06	0.000133	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.78e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.76e-06	0.00013	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.72e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.68e-06	0.000128	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.68e-06	0.000128	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.41e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.36e-06	0.00012	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	5.19e-06	0.000117	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.19e-06	0.000117	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	5.18e-06	0.000117	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	5.17e-06	0.000116	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5.1e-06	0.000115	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.1e-06	0.000115	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.01e-06	0.000113	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.01e-06	0.000113	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5e-06	0.000112	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.99e-06	0.000112	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.95e-06	0.000111	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.9e-06	0.00011	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.9e-06	0.00011	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.9e-06	0.00011	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.9e-06	0.00011	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.87e-06	0.00011	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.82e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.81e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.81e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.77e-06	0.000107	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.77e-06	0.000107	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.77e-06	0.000107	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.76e-06	0.000107	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.75e-06	0.000107	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.73e-06	0.000106	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.67e-06	0.000105	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.66e-06	0.000105	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.63e-06	0.000104	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.61e-06	0.000104	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.61e-06	0.000104	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.55e-06	0.000102	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.55e-06	0.000102	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.54e-06	0.000102	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.49e-06	0.000101	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.46e-06	0.0001	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.44e-06	9.97e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.36e-06	9.81e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.35e-06	9.77e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.28e-06	9.63e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.28e-06	9.63e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.28e-06	9.63e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	4.28e-06	9.62e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.26e-06	9.57e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.23e-06	9.52e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.2e-06	9.45e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.18e-06	9.4e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.18e-06	9.39e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.17e-06	9.36e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.08e-06	9.16e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.05e-06	9.09e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.01e-06	9.02e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.98e-06	8.94e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.96e-06	8.91e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.94e-06	8.85e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.92e-06	8.81e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.92e-06	8.8e-05	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.9e-06	8.75e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.87e-06	8.7e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.87e-06	8.7e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.86e-06	8.67e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.83e-06	8.62e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.81e-06	8.57e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.75e-06	8.43e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.74e-06	8.4e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.71e-06	8.35e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.71e-06	8.35e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.69e-06	8.3e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.65e-06	8.2e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.61e-06	8.11e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.54e-06	7.95e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.45e-06	7.76e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.39e-06	7.61e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	3.36e-06	7.56e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.28e-06	7.36e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.25e-06	7.31e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.2e-06	7.19e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.2e-06	7.19e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.19e-06	7.17e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.19e-06	7.16e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.14e-06	7.06e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.1e-06	6.98e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.05e-06	6.86e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.01e-06	6.76e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.97e-06	6.67e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.97e-06	6.67e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.97e-06	6.67e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.95e-06	6.62e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.93e-06	6.58e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.91e-06	6.55e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.85e-06	6.41e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.84e-06	6.39e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.8e-06	6.29e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.8e-06	6.29e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.77e-06	6.22e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.73e-06	6.14e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.72e-06	6.1e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.62e-06	5.9e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.57e-06	5.78e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.56e-06	5.75e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.49e-06	5.6e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.45e-06	5.51e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.44e-06	5.49e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.41e-06	5.43e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	2.27e-06	5.09e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.13e-06	4.78e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.09e-06	4.7e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.09e-06	4.69e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.91e-06	4.3e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.83e-06	4.11e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.83e-06	4.11e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.67e-06	3.76e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.37e-06	3.07e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.29e-06	2.89e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.41e-07	1.89e-05	CbGpPWpGaD
